Literature DB >> 20175969

Lactic acid bacteria as adjuvants for sublingual allergy vaccines.

Laurence Van Overtvelt1, Helene Moussu, Stéphane Horiot, Sandrine Samson, Vincent Lombardi, Laurent Mascarell, Ariane van de Moer, Raphaëlle Bourdet-Sicard, Philippe Moingeon.   

Abstract

We compared immunomodulatory properties of 11 strains of lactic acid bacteria as well as their capacity to enhance sublingual immunotherapy efficacy in a murine asthma model. Two types of bacterial strains were identified, including: (i) potent inducers of IL-12p70 and IL-10 in dendritic cells, supporting IFN-gamma and IL-10 production in CD4+ T cells such as Lactobacillus helveticus; (ii) pure Th1 inducers such as L. casei. Sublingual administration in ovalbumin-sensitized mice of L. helveticus, but not L. casei, reduced airways hyperresponsiveness, bronchial inflammation and proliferation of specific T cells in cervical lymph nodes. Thus, probiotics acting as a Th1/possibly Treg, but not Th1 adjuvant, potentiate tolerance induction via the sublingual route. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20175969     DOI: 10.1016/j.vaccine.2010.02.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

2.  Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium.

Authors:  P C D Ferreira; J B da Silva; R M F Piazza; L Eckmann; P L Ho; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

3.  [Sublingual immunotherapy. Where are we now?].

Authors:  H Lee; T Zuberbier; M Worm
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

4.  High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs.

Authors:  Ke Wen; Guohua Li; Tammy Bui; Fangning Liu; Yanru Li; Jacob Kocher; Lin Lin; Xingdong Yang; Lijuan Yuan
Journal:  Vaccine       Date:  2011-12-14       Impact factor: 3.641

Review 5.  Adjuvants for allergy vaccines.

Authors:  Philippe Moingeon
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 6.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 7.  Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.

Authors:  Yamini V Virkud; Julie Wang; Wayne G Shreffler
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

8.  Ex Vivo Immunomodulatory Effects of Lactobacillus-, Lacticaseibacillus-, and Bifidobacterium-Containing Synbiotics on Human Peripheral Blood Mononuclear Cells and Monocyte-Derived Dendritic Cells in the Context of Grass Pollen Allergy.

Authors:  Alexander Heldner; Matthew D Heath; Benjamin Schnautz; Sebastian Kotz; Adam Chaker; Matthias F Kramer; Constanze A Jakwerth; Ulrich M Zissler; Carsten B Schmidt-Weber; Simon Blank
Journal:  Probiotics Antimicrob Proteins       Date:  2022-02-03       Impact factor: 4.609

Review 9.  Induction of tolerance via the sublingual route: mechanisms and applications.

Authors:  Philippe Moingeon; Laurent Mascarell
Journal:  Clin Dev Immunol       Date:  2011-11-10

10.  Therapeutic effects and biomarkers in sublingual immunotherapy: a review.

Authors:  Takashi Fujimura; Yoshitaka Okamoto; Masaru Taniguchi
Journal:  J Allergy (Cairo)       Date:  2012-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.